No known contraindication, and Mayo Clinic ENDO 2025 (120 postmenopausal women) showed tirzepatide plus HRT produced 17% weight loss vs 14% for tirzepatide alone
stomach emptying and gut motility go down to give you a longer feeling of fullness), in the liver (reduced glucose production
This process allows them to create doses, concentrations, and formulations that may differ from the standardized brand-name products
Skin sensitivity has been reported by some researchers, potentially related to the metabolic shifts induced by the triple agonist mechanism
The bottom line : theres currently no evidence that GLP-1 agonists enhance actual athletic performance in humans, and there are plausible reasons to worry they could hinder performance by reducing muscle and interfering with fuelling (more on that below)
On average, patients lose about 20 to 25% of their body weight with surgery